FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

cobas pulse blood glucose monitoring system

K Number: K252323 · Decision Jun 12, 2026
Classifications
1
FEI Numbers
8
Registration Numbers
8
Same Product Code
13
Applicant Total
183
Review Days
322

Basic Information

Device Name
cobas pulse blood glucose monitoring system
K Number
K252323
Device Class
FDA class 2
Clearance Type
Dual Track
Regulation Number
862.1345
Medical Specialty
Clinical Chemistry
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Roche Diagnostics
Date Received
July 25, 2025
Decision Date
June 12, 2026
Product Code
PZI
Advisory Committee
Clinical Chemistry
Review Advisory Committee
CH
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
PZI Prescription Use Blood Glucose Meter For Near-Patient Testing

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (PZI), ordered by most recent decision date.

View all

Other Clearances by Roche Diagnostics

K Number Device Name
K252280 Elecsys Anti-SARS-CoV-2 S
K260048 Elecsys Anti-HAV IgM
K260049 Elecsys Anti-HBc IgM
K260046 Elecsys Anti-HBc II
K260026 Tina-quant Cardiac high sensitivity CRP III
K253490 Glucose HK Gen.3; ONLINE DAT Methadone II; cobas pro integrated solutions
K253491 ISE indirect K for Gen.2; ISE indirect Na for Gen.2; ISE indirect Cl for Gen.2; cobas pro integrated solutions
K253839 Elecsys Anti-SARS-CoV-2
K253188 CoaguChek XS Plus System
K252163 Elecsys Phospho-Tau (181P) Plasma
Search all 183 clearances from Roche Diagnostics →